同位素稀释高效液相色谱-串联质谱法测定水体、底泥、鱼及虾中氯硝柳胺残留量

建立了水体、底泥、鱼体自然比例带皮肌肉和虾肌肉中氯硝柳胺(NIC)残留量测定的同位素稀释高效液相色谱-串联质谱(HPLC-MS/MS)法。水样经碱化后以乙酸乙酯提取,其他样品采用0.1%氨水乙腈提取,C_(18)粉进行样品净化。以乙腈-水为流动相,流速为0.3 mL/min,采用Thermo Hypersil Gold C_(18)(150 mm×2.1 mm,5μm)色谱柱进行分离,氯硝柳胺稳定同位素标记物(氯硝柳胺-~(13)C_6)为内标,选择反应监测(SRM)模式扫描,内标法定量。结果表明氯硝柳胺在0.2～200μg/L范围内呈良好线性关系,相关系数(r~2)不小于0.999 5。空白水样在2.5、25、250 ng/L加标水平下的平均回收率为90.5%～109%,相对标准偏差(RSD)为3.2%～11%,检出限(LOD)为1.0 ng/L,定量下限(LOQ)为2.5 ng/L;空白底泥、黄颡鱼自然比例带皮肌肉和克氏原螯虾肌肉在0.5、5.0、50μg/kg加标水平下的平均回收率分别为89.4%～113%、92.8%～110%和94.1%～107%,RSD分别为4.6%～12%、2.8%～11%和3.2%～9.3%,LOD均为0.2μg/kg,LOQ均为0.5μg/kg。该方法的灵敏度、准确度和选择性高,适用于实际水产养殖环境水体、底泥、鱼和虾中氯硝柳胺的残留分析。     

氯硝柳胺衍生物的合成及抗肿瘤活性研究

以氯硝柳胺为起始原料,经醚化、亲核取代反应得到目标化合物,采用MTT法考察所合成化合物对人类乳腺癌细胞(MDA-MB-231)和人类胰腺癌细胞(ASPC-1)的体外抗肿瘤活性。合成了5个氯硝柳胺衍生物,其结构均经IR、1H-NMR、13C-NMR和MS确证。初步的体外抗肿瘤活性结果显示目标化合物9b和9c的抗肿瘤活性强于阳性对照药,其中化合物9b的活性对所测两种肿瘤株的抑制活性均强于阳性对照药,展现出较强的应用前景。     

Niclosamide Is Active In Vitro against Mycetoma Pathogens

Redox-active drugs are the mainstay of parasite chemotherapy. To assess their repurposing potential for eumycetoma, we have tested a set of nitroheterocycles and peroxides in vitro against two isolates of Madurella mycetomatis, the main causative agent of eumycetoma in Sudan. All the tested compounds were inactive except for niclosamide, which had minimal inhibitory concentrations of around 1 µg/mL. Further tests with niclosamide and niclosamide ethanolamine demonstrated in vitro activity not only against M. mycetomatis but also against Actinomadura spp., causative agents of actinomycetoma, with minimal inhibitory concentrations below 1 µg/mL. The experimental compound MMV665807, a related salicylanilide without a nitro group, was as active as niclosamide, indicating that the antimycetomal action of niclosamide is independent of its redox chemistry (which is in agreement with the complete lack of activity in all other nitroheterocyclic drugs tested). Based on these results, we propose to further evaluate the salicylanilides, niclosamide in particular, as drug repurposing candidates for mycetoma.     

In silico study of novel niclosamide derivatives,SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-mediated coronavirus disease 2019 (COVID-19) infection remains a global pandemic and health emergency with overwhelming social and economic impacts throughout the world. Therapeutics for COVID-19 are limited to only remdesivir; therefore, there is a need for combined, multidisciplinary efforts to develop new therapeutic molecules and explore the effectiveness of existing drugs against SARS-CoV-2. In the present study, we reported eight (SCOV-L-02, SCOV-L-09, SCOV-L-10, SCOV-L-11, SCOV-L-15, SCOV-L-18, SCOV-L-22, and SCOV-L-23) novel structurally related small-molecule derivatives of niclosamide (SCOV-L series) for their targeting potential against angiotensin-converting enzyme-2 (ACE2), type II transmembrane serine protease (TMPRSS2), and SARS-COV-2 nonstructural proteins (NSPs) including NSP5 (3CLpro), NSP3 (PLpro), and RdRp. Our correlation analysis suggested that ACE2 and TMPRSS2 modulate host immune response via regulation of immune-infiltrating cells at the site of tissue/organs entries. In addition, we identified some TMPRSS2 and ACE2 microRNAs target regulatory networks in SARS-CoV-2 infection and thus open up a new window for microRNAs-based therapy for the treatment of SARS-CoV-2 infection. Our in vitro study revealed that with the exception of SCOV-L-11 and SCOV-L-23 which were non-active, the SCOV-L series exhibited strict antiproliferative activities and non-cytotoxic effects against ACE2- and TMPRSS2-expressing cells. Our molecular docking for the analysis of receptor-ligand interactions revealed that SCOV-L series demonstrated high ligand binding efficacies (at higher levels than clinical drugs) against the ACE2, TMPRSS2, and SARS-COV-2 NSPs. SCOV-L-18, SCOV-L-15, and SCOV-L-09 were particularly found to exhibit strong binding affinities with three key SARS-CoV-2’s proteins: 3CLpro, PLpro, and RdRp. These compounds bind to the several catalytic residues of the proteins, and satisfied the criteria of drug-like candidates, having good adsorption, distribution, metabolism, excretion, and toxicity (ADMET) pharmacokinetic profile. Altogether, the present study suggests the therapeutic potential of SCOV-L series for preventing and managing SARs-COV-2 infection and are currently under detailed investigation in our lab.     

Expanding the structural landscape of niclosamide: a high Z′ polymorph,two new solvates and monohydrate HA

Three new crystalline phases are reported for the drug niclosamide [5‐chloro‐N‐(2‐chloro‐4‐nitrophenyl)‐2‐hydroxybenzamide], C₁₃H₈Cl₂N₂O₄. A new high‐Z′ polymorph (denoted Form II) is described, with four molecules in the asymmetric unit in the space group P2/n. The structure exhibits pseudosymmetry, including local translations and screw‐type operations. The niclosamide molecules are linked by O—H...O hydrogen bonds into chains, and the chains are packed so that the molecules form face‐to‐face (stacking) and end‐to‐end interactions within layers perpendicular to the chains. There are two different layer arrangements, giving a structure that is relatively complex. In the acetone and acetonitrile solvates, the incorporated solvent molecules accept hydrogen bonds from the OH groups of niclosamide, and the niclosamide molecules are stacked in a face‐to‐face manner. In the acetone solvate, C₁₃H₈Cl₂N₂O₄·C₃H₆O, V‐shaped arrangements are formed in which the nitrobenzene ends of the niclosamide molecules are brought into face‐to‐face contact. In the acetonitrile solvate, C₁₃H₈Cl₂N₂O₄·CH₃CN, stacking occurs by translation along a short axis (ca 3.8 Å) and the crystals are frequently observed to be twinned by twofold rotation around that axis. The acetonitrile molecules occupy channels in the structure. A complete structure is provided for niclosamide monohydrate, C₁₃H₈Cl₂N₂O₄·H₂O, polymorph H_A, obtained by Rietveld refinement against laboratory powder X‐ray diffraction data. It has been suggested that this compound is related to the methanol solvate of niclosamide [Harriss, Wilson & Radosevljevic Evans (2014). Acta Cryst. C 70 , 758–763], but it is found that the two are not fully isostructural: they contain isostructural two‐dimensional layers, but the layers are arranged differently in the two structures. This suggests that H_A may have the potential for polytypism, and features in the Rietveld difference curve indicate that a polytype fully isostructural with the methanol solvate might be present.     

Validation of QuEChERS-based UPLC-MS/MS method for determination of quinoid niclosamide (LDS) residue in water,soil and rice samples

A sensitive, rapid and easy analytical method was validated for the determination of quinoid niclosamide (LDS) molluscicide in water, rice and soil using a QuEChERS extraction procedure and ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) detection. The LDS was extracted by using acetonitrile and then cleaned up by using dispersive solid-phase extraction with florisil and C18 sorbents. The determination of the target compound was achieved in less than 3 min using an electrospray ionisation source in negative mode. The overall average recoveries for this method in water, rice and soil matrix at three fortified levels ranged from 82.54 to 99.9%, with relative standard deviations in the range of 1.51 to 4.86% (n = 5). The calculated limits of detection were lower than 0.1 µg kg^?1 and quantification was 5 µg kg^?1; these values were much lower than the maximum residue levels established by the Australian standard (0.01 mg kg^?1). The results of the method validation confirmed that this proposed method is convenient and reliable for the determination of LDS molluscicide in water, rice and soil samples.     

氯硝柳胺透皮控释给药的研究

用Ｖａｌｉａ－Ｃｈｉｅｎ双室扩散池进行了氯硝柳胺体外透皮的研究，发现氯硝柳胺乙醇混悬液有较高的渗透速率且服从零级动力学模型，透皮促进剂油酸比氮酮具有更好的促渗作用，氮酮与丙二醇或油酸合用均有协同作用．研究结果表明，氯硝柳胺能制成长效贴剂，且在２３～７２ｈ之间缓慢平稳释药．用ＩＲ、ＤＳＣ研究了氮酮和油酸的作用机理．     

Niclosamide methanol solvate and niclosamide hydrate: structure,solvent inclusion mode and implications for properties

Structural studies have been carried out of two solid forms of niclosamide [5‐chloro‐N‐(2‐chloro‐4‐nitrophenyl)‐2‐hydroxybenzamide, NCL], a widely used anthelmintic drug, namely niclosamide methanol monosolvate, C₁₃H₈Cl₂N₂O₄·CH₃OH or NCL·MeOH, and niclosamide monohydrate, denoted H_A. The structure of the methanol solvate obtained from single‐crystal X‐ray diffraction is reported for the first time, elucidating the key host–guest hydrogen‐bonding interactions which lead to solvate formation. The essentially planar NCL host molecules interact viaπ‐stacking and pack in a herringbone‐type arrangement, giving rise to channels along the crystallographic a axis in which the methanol guest molecules are located. The methanol and NCL molecules interact via short O—H...O hydrogen bonds. Laboratory powder X‐ray diffraction (PXRD) measurements reveal that the initially phase‐pure NCL·MeOH solvate readily transforms into NCL monohydrate within hours under ambient conditions. PXRD further suggests that the NCL monohydrate, H_A, is isostructural with the NCL·MeOH solvate. This is consistent with the facile transformation of the methanol solvate into the hydrate when stored in air. The crystal packing and the topology of guest‐molecule inclusion are compared with those of other NCL solvates for which the crystal structures are known, giving a consistent picture which correlates well with known experimentally observed desolvation properties.     

高效液相色谱法分析水稻和稻田中的氯硝柳胺乙醇胺盐残留

建立了高效液相色谱(HPLC)测定水稻和稻田中氯硝柳胺乙醇胺盐残留量的分析方法。稻田水和稻秆样品中的氯硝柳胺乙醇胺盐残留用碱性乙酸乙酯直接提取;而稻田土壤、糙米和谷壳样品则先经碱性乙醇提取,再用乙酸乙酯进行萃取。萃取物经弗罗里硅土柱净化后,经Welchrom C18柱分离,采用紫外检测器检测,外标法定量。在0.01～10.00 mg/L范围内,氯硝柳胺乙醇胺盐的峰面积与其质量浓度间呈良好的线性关系,相关系数为0.9998。在稻田水、土壤、稻秆、糙米和谷壳中添加0.01～5.00 mg/kg的氯硝柳胺乙醇胺盐,其平均回收率为93.47%～100.9%,相对标准偏差为1.46%～5.82%,符合农药残留量分析与检测的技术要求。该方法简便、快速,灵敏度高,重现性好,可用于环境系统中氯硝柳胺乙醇胺盐残留量的分析与检测。     

Polymeric controlled release formulations of niclosamide for control of Biomphalaria alexandrina, the vector snail of schistosomiasis

Schistosomiasis is one of the most important public health problems in many developing countries. The present study was conducted to investigate the effect of the polymeric niclosamide formulations against Biomphalaria alexandrina snails, the intermediate host of Schistosoma mansoni in Egypt. Three new polymeric formulations were prepared for the molluscicide niclosamide. The formulations were prepared either by the chemical modifications of poly(glycidyl methacrylate) or by physical entrapment of the niclosamide in calcium alginate beads. The release of the niclosamide from the polymeric formulations was investigated. The activity of the prepared formulations against Biomphalaria alexandrina was investigated. The results obtained revealed higher potency for polymerized niclosamide B3 than B1; the lowest potency was revealed for B2. After an exposure period of 24 hours, LC(50) values were 0.073, 0.098 and 1.09 ppm for B3, B1 and B2, respectively. In addition, the molluscicidal potency of the test polymeric niclosamide was age-dependent, where old snails were more tolerant to the test solutions than young and newly hatched snails. The results also indicated that the molluscicidal activity of B3 was extended for 21 days and 17 days for B1, compared with 5 days for free niclosamide. However, the molluscicidal potency of the polymerized niclosamide was increased after boiling for one hour, and was increased with increasing the pH of the medium to pH 9. In addition, their potency was increased with decreasing the water hardness concentrations (CaCO(3)).Molluscicidal activity of free niclosamide and its polymeric formulations vs. exposure time.